首页> 美国卫生研究院文献>Springer Open Choice >Synthesis characterization and pharmacological evaluation of novel azolo- and azinothiazinones containing 24-dihydroxyphenyl substituent as anticancer agents
【2h】

Synthesis characterization and pharmacological evaluation of novel azolo- and azinothiazinones containing 24-dihydroxyphenyl substituent as anticancer agents

机译:含有24-二羟基苯基取代基的新型偶氮和叠氮基叠氮酮类化合物的合成表征和药理学评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AbstractWe reported the synthesis and characterization of a series of azolo- and azino[1,3]thiazinones containing the 2,4-dihydroxyphenyl substituent. The compounds were prepared by a new one-step reaction of aryl-modified sulfinylbis[(2,4-dihydroxyphenyl)methanethione]s and the corresponding aminoazolo(azino)carboxamides. Their chemical structures were confirmed by IR, NMR: 1H, 13C, HSQC, and EI-MS spectral data. The compounds inhibited proliferation and viability of lung cancer A549, colon cancer HT-29, and glioma C6 cells in a structure- and concentration-dependent manner. The activity of some analogues was below 10 μmol dm−3 (IC50). Glioma C6 cells were the most sensitive to tested compounds. Generally, the derivatives were not toxic for the skin fibroblast HSF culture. Moreover, some of them exerted a protective effect on the treated normal cells. Evaluation of compound properties in silico showed that they possess significant drug-like characteristics and most of them display a low toxicity.
机译:摘要我们报道了一系列含2,4-二羟基苯基取代基的偶氮-和叠氮[1,3]噻嗪酮的合成和表征。通过芳基改性的亚磺酰基双[(2,4-二羟基苯基)甲烷硫酮]与相应的氨基偶氮(叠氮基)羧酰胺的新的一步反应制备化合物。它们的化学结构通过IR,NMR证实: 1 H, 13 C,HSQC和EI-MS光谱数据。这些化合物以结构和浓度依赖性方式抑制肺癌A549,结肠癌HT-29和神经胶质瘤C6细胞的增殖和生存能力。一些类似物的活性低于10μmoldm -3 (IC50)。胶质瘤C6细胞对测试化合物最敏感。通常,该衍生物对皮肤成纤维细胞HSF培养无毒。此外,它们中的一些对处理过的正常细胞具有保护作用。在计算机上对化合物特性的评估表明,它们具有明显的类药物特性,并且大多数都显示出低毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号